Sage Journals: Discover world-class research

Abstract

Objective

To evaluate national and regional trends in age-standardized mortality rates (ASMRs) from childhood-onset systemic lupus erythematosus (cSLE) in Mexico between 2000 and 2023, stratified by sex and region.

Methods

This cross-sectional, retrospective study used the INEGI national death registry via the Public Health Intelligence Unit (UISP-INSP). Deaths in children aged 1–14 years attributed to cSLE were identified using ICD-10 codes M32.1, M32.8, and M32.9, excluding M32.0. ASMRs per 100,000 population were calculated using the 2010 Mexican census as a reference. Trends by year, sex, and region were analyzed using Poisson regression models with log link and population offset. Incidence rate ratios (IRRs) with 95% confidence intervals were estimated.

Results

From 2000 to 2023, 637 cSLE deaths were recorded among 280,334 child deaths. Females accounted for 80.4% (ASMR 0.13; 95% CI 0.12–0.15), nearly fourfold higher than males (0.03; 95% CI 0.03–0.04). Although the Central and Midwest regions concentrated over 60% of total deaths, ASMRs were similar across regions (range 0.08–0.09 per 100,000). No consistent temporal trend in mortality was observed. Poisson regression confirmed significantly lower mortality in boys compared to girls (IRR 0.24; 95% CI 0.19–0.29; p < 0.001) with no statistically significant regional differences.

Conclusions

cSLE mortality in Mexico has remained stable over time, with a marked female predominance. The regional distribution of deaths likely reflects population density rather than major differences in mortality risk. Strengthening early diagnosis, paediatric rheumatology care networks, and national surveillance systems is essential to reduce disease burden.

Keywords

childhood-onset systemic lupus erythematosus Mexico mortality trends paediatric rheumatology

Get full access to this article

View all access options for this article.

References

Yen

Singh

. Brief report: lupus-an unrecognized leading cause of death in young females: a population-based study using nationwide death certificates, 2000-2015. Arthritis Rheumatol 2018; 70: 1251–1255. https://doi.org/10.1002/art.40512

Etchegaray-Morales

Mendoza-Pinto

Munguía-Realpozo

, et al. Systemic lupus erythematosus, a leading cause of death in young Mexican females: a nationwide population-based study, 2000-2020. Rheumatol Int 2022; 42: 1715–1720. https://doi.org/10.1007/s00296-022-05154-9

Moe

Haukeland

Brunborg

, et al. Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022. Rheumatology 2024; 63: 2109–2117. https://doi.org/10.1093/rheumatology/kead519

Malham

Jansson

Ingels

, et al. Paediatric-onset immune-mediated inflammatory disease is associated with an increased mortality risk: a nationwide study. Aliment Pharmacol Ther 2024; 59: 1551–1558. https://doi.org/10.1111/apt.17994

Torrente-Segarra

Salman Monte

Rúa-Figueroa

, et al. Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Semin Arthritis Rheum 2019; 48: 1025–1029. https://doi.org/10.1016/j.semarthrit.2018.09.005

Roberts

Faino

Bryan

, et al. Hospitalization and mortality due to infection among children and adolescents with systemic lupus erythematosus in the United States. J Rheumatol 2024; 51: 891–898. https://doi.org/10.3899/jrheum.2023-1219

Tektonidou

Lewandowski

, et al. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 2017; 76: 2009–2016. https://doi.org/10.1136/annrheumdis-2017-211663

Abujam

Gupta

Suri

, et al. Trends and predictors of mortality in childhood onset lupus in a single North-Indian centre over 23 years: a retrospective study. Clin Exp Rheumatol 2016; 34: 554–559.

Gao

, et al. Childhood-onset systemic lupus erythematosus in China, 2016-21: a nationwide study. Lancet Child Adolesc Health 2024; 8: 762–772. https://doi.org/10.1016/S2352-4642(24)00172-X

10.

INEGI . Resultados del Censo de Población, 2020. https://www.inegi.org.mx/servicios/widgets_poblacion.html (accessed 28 March 2025).

11.

DGIS.

Datos abiertos. Secretaría de Salud/Dirección General de Información en Salud. https://www.dgis.salud.gob.mx/contenidos/basesdedatos/Datos_Abiertos_gobmx.html (accessed 1 February 2025).

12.

Valenzuela-Almada

Hocaoglu

Dabit

, et al. Epidemiology of childhood-onset systemic lupus erythematosus: a population-based study. Arthritis Care Res 2022; 74: 728–732. https://doi.org/10.1002/acr.24827

13.

Sakamoto

Silva

Pita

, et al. Risk factors for mortality in 1528 Brazilian childhood-onset systemic lupus erythematosus patients. Lupus 2023; 32: 781–790. https://doi.org/10.1177/09612033231170515

14.

Hersh

Trupin

Yazdany

, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res 2010; 62: 1152–1159. https://doi.org/10.1002/acr.20179

15.

Tucker

Uribe

Fernández

, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008; 17: 314–322. https://doi.org/10.1177/0961203307087875

16.

Christou

EAA

Aggelos

Despoina

, et al. Sexual dimorphism in SLE: above and beyond sex hormones. Lupus 2018; 28: 3–10. https://doi.org/10.1177/0961203318815768

17.

Patel

Yang

Nagra

, et al. Association of race and ethnicity with mortality in adults with SLE: a systematic literature review and meta-analysis. Lupus Sci Med 2025; 12: e001383. https://doi.org/10.1136/lupus-2024-001383

18.

Martínez-Martínez

Rodríguez-Brito

. Vulnerability in health and social capital: a qualitative analysis by levels of marginalization in Mexico. Int J Equity Health 2020; 19: 24. https://doi.org/10.1186/s12939-020-1138-4

19.

Mendoza-Pinto

Etchegaray-Morales

Ugarte-Gil

. Improving access to SLE therapies in low and middle-income countries. Rheumatology 2023; 62: i30–i35. https://doi.org/10.1093/rheumatology/keac530

20.

Calvo-Alén

Alarcón

Campbell

, et al. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology 2005; 44: 1186–1189. https://doi.org/10.1093/rheumatology/keh717

21.

National Academies of Sciences . Engineering and medicine. U.S. mortality data: data quality, methodology, and recommendations. In: Becker

Majmundar

Harris

(eds). High and Rising Mortality Rates Among Working-Age Adults, 2021.

22.

Seitz

Deliens

Cohen

, et al. Feasibility of using death certificates for studying place of death in Latin America. Rev Panam Salud Publica 2021; 45: e149. https://doi.org/10.26633/RPSP.2021.149

23.

Mendoza-Pinto

Etchegaray-Morales

Garcia-Carrasco

, et al. Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: results from a nationwide health registry. Lupus 2022; 31: 382–391. https://doi.org/10.1177/09612033221078228

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.30 MB

Nationwide analysis of childhood-onset systemic lupus erythematosus mortality in Mexico,2000–2023

Abstract

Objective

Methods

Results

Conclusions

Keywords

Get full access to this article

References

Supplementary Material